PMC:7299399 / 14808-14915 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7299399","sourcedb":"PMC","sourceid":"7299399","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7299399","text":"reasons, when designing antiviral drugs, clearance mechanisms have to be kept in mind. An example of this p","tracks":[{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T89","span":{"begin":24,"end":39},"obj":"Chemical"},{"id":"T90","span":{"begin":24,"end":33},"obj":"Chemical"},{"id":"T91","span":{"begin":34,"end":39},"obj":"Chemical"}],"attributes":[{"id":"A89","pred":"chebi_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/CHEBI_36044"},{"id":"A90","pred":"chebi_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A91","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"subj":"T89","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T90","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T91","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CHEBI","color":"#93d3ec","default":true}]}]}}